Finance

Beta
Lists
MBIO:NASDAQ
Mustang Bio Inc
$0.74
0.00%
(0.00) 1D
Jun 10, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MBIO...
Mkt. cap
5.60M
Avg. vol.
229.16K
Volume
117.00
52-wk high
$7.00
52-wk low
$0.53
EPS
-$0.49
Beta
2.08
Shares outstanding
6.73M
No. of employees
4
Mkt. cap
5.60M
Avg. vol.
229.16K
Volume
117.00
52-wk high
$7.00
52-wk low
$0.53
EPS
-$0.49
Beta
2.08
Shares outstanding
6.73M
No. of employees
4
News stories
From sources across the web
Profile
Mustang Bio is an American clinical-stage biopharmaceutical company founded in 2015 and headquartered in Worcester, MA, U.S. Operating as a partner company of Fortress Biotech, Mustang Bio develops CAR-T immunotherapies and gene therapies for multiple diseases, including hematologic cancers, solid tumors, and X-linked severe combined immunodeficiency. Wikipedia
About Mustang Bio Inc
CEOManuel Litchman
Employees4
Founded2015
HeadquartersWaltham, Massachusetts, United States
SectorBiotechnology
Websitemustangbio.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
98.00K
-333.00K
-317.00K
178.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
787.00K
957.00K
987.00K
880.00K
Operating expense
885.00K
624.00K
670.00K
1.06M
Total operating expenses
885.00K
624.00K
670.00K
1.06M
Operating income
-885.00K
-624.00K
-670.00K
-1.06M
Other non operating income
-
-
-
-
EBT including unusual items
-762.00K
-468.00K
-538.00K
-955.00K
EBT excluding unusual items
-762.00K
-468.00K
-538.00K
-955.00K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-762.00K
-468.00K
-538.00K
-955.00K
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
123.00K
156.00K
132.00K
103.00K
Interest expense
-
-
-
-
Net interest expenses
123.00K
156.00K
132.00K
103.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-885.00K
-624.00K
-670.00K
-1.05M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer